The National Institute on Drug Abuse (NIDA) recently awarded Johns Hopkins University $774,845 in funding to support its drug use and addiction research
The university’s research aims to discover innovative intervention treatment for opioid-use disorders. Funding will be used to allow researchers to evaluate the effectiveness of the Bridge Device, a neuromodulator that helps patients with opioid-withdrawal symptoms.
Founded in 2009, the Johns Hopkins Drug Discovery Program is comprised of scientists studying the impacts of drugs on the human neurological system, biochemistry, drug metabolism, and toxicology.
“The opioid epidemic – exacerbated by the COVID-19 pandemic – continues to upend communities and destroy lives across Maryland and our nation,” U.S. Sens. Chris Van Hollen (D-MD) and Ben Cardin (D-MD) and Reps. Dutch Ruppersberger (D-MD), John Sarbanes (D-MD) and Kweisi Mfume (D-MD) said in a joint statement. “This funding will provide crucial support in evaluating a potential new tool for expanding substance use disorder treatment and recovery. We will keep fighting to increase access to recovery resources and save the lives of those who suffer from this terrible disease.”
Between 1999 and 2018, more than 450,000 Americans died from opioid overdose.
NIDA studies the consequences of opioids and addiction to inform and protect the public.